letters to the editorTrabectedin is an effective second-line treatment in soft tissue sarcoma patients
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2016 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.